HomeEWL • FRA
add
Edwards Lifesciences Corp
Nakaraang pagsara
€78.11
Sakop ng araw
€79.54 - €79.54
Sakop ng taon
€57.10 - €88.92
Market cap
51.31B USD
Average na Volume
107.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.60B | 9.50% |
Gastos sa pagpapatakbo | 774.90M | 5.50% |
Net na kita | 351.90M | 3.35% |
Net profit margin | 22.02 | -5.62% |
Kita sa bawat share | 0.66 | 6.45% |
EBITDA | 476.20M | 10.54% |
Aktuwal na % ng binabayarang buwis | 14.26% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.70B | 35.35% |
Kabuuang asset | 9.74B | 12.54% |
Kabuuang sagutin | 2.55B | -1.52% |
Kabuuang equity | 7.19B | — |
Natitirang share | 602.60M | — |
Presyo para makapag-book | 6.61 | — |
Return on assets | 11.46% | — |
Return on capital | 14.30% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 351.90M | 3.35% |
Cash mula sa mga operasyon | -53.50M | -117.03% |
Cash mula sa pag-invest | 63.10M | 12,520.00% |
Cash mula sa financing | 61.70M | 129.86% |
Net change in cash | 81.00M | -21.97% |
Malayang cash flow | 105.16M | -42.92% |
Tungkol
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia
Itinatag
1958
Headquarters
Website
Mga Empleyado
19,800
